ストックスクリーナーアプリを入手
4.89
5.62%
0.26
アフターアワーズ：
5.00
0.11
+2.25%
前日終値:
$4.63
開ける：
$4.6
24時間の取引高:
2.55M
Relative Volume:
7.37
時価総額：
$30.37M
収益：
-
当期純損益:
$-26.56M
株価収益率:
-0.1106
EPS:
-44.2199
ネットキャッシュフロー:
$-28.59M
1週間 パフォーマンス:
+11.90%
1か月 パフォーマンス:
-36.82%
6か月 パフォーマンス:
+511.71%
1年 パフォーマンス:
-15.70%
1日の値動き範囲:
$4.50
$5.01
1週間の範囲:
$4.17
$5.01
52週間の値動き範囲:
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
名前
Briacell Therapeutics Corp
セクター
電話
(604) 921-1810
住所
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
BCTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
4.89 | 28.76M | 0 | -26.56M | -28.59M | -44.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-02-14 | 開始されました | H.C. Wainwright | Buy |
Briacell Therapeutics Corp (BCTX) 最新ニュース
BriaCell reports long-term survival data in metastatic breast cancer By Investing.com - Investing.com India
BriaCell Therapeutics Corp. - Baystreet.ca
BriaCell (BCTX) Reports Promising Phase 2 Survival Data - GuruFocus
BriaCell Therapeutics Says Phase 2 Metastatic Breast Cancer Patients Survival Data Exceed Benchmarks - marketscreener.com
BriaCell's New Therapy Significantly Extends Survival in Breast Cancer Patients - Intellectia AI
BriaCell reports long-term survival data in metastatic breast cancer - Investing.com
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients - The Manila Times
Growth Value: Is BriaCell Therapeutics Corp a defensive stockJuly 2025 Rallies & Step-by-Step Trade Execution Guides - baoquankhu1.vn
(BCT) Strategic Investment Report (BCT:CA) - Stock Traders Daily
Smart Money: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trendsLayoff News & Weekly Stock Breakout Alerts - baoquankhu1.vn
(BCT) Strategic Equity Report (BCT:CA) - Stock Traders Daily
(BCT) Stock Trading Blueprint (BCT:CA) - Stock Traders Daily
Is the Market Bullish or Bearish on BriaCell Therapeutics Corp? - Benzinga
Market Moves: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returnsWeekly Trade Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
Surprises Report: Is Simpple Ltd stock a value trapJuly 2025 PostEarnings & Free Community Supported Trade Ideas - baoquankhu1.vn
ETF Watch: Does BriaCell Therapeutics Corp have a sustainable dividendMarket Risk Analysis & Verified Stock Trade Ideas - baoquankhu1.vn
The Globe’s stars and dogs for the week - The Globe and Mail
Philadelphia cancer therapy developer raises $30M amid signs of thaw in biotech funding - The Business Journals
Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch - RTTNews
BriaCell closes $30 million public offering to fund cancer immunotherapy By Investing.com - Investing.com Nigeria
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit - MSN
BriaCell Therapeutics Completes $30 Million Public Offering - TipRanks
BriaCell closes $30 million public offering to fund cancer immunotherapy - Investing.com India
BriaCell Therapeutics Announces Closing of US$30 million Public Offering - Investing News Network
BriaCell Therapeutics Signs Multiple Material Agreements - TradingView
Why did BCTX stock surge 50% today? - MSN
BriaCell stock notches best day in 5 years on breast cancer data — then drops 10% after-hours: What went wrong? - MSN
BriaCell Therapeutics shares sink after $30 million capital raise - MSN
Market Review: Whats the profit margin of BriaCell Therapeutics Corp Equity Warrant2025 Pullback Review & Long-Term Growth Stock Strategies - baoquankhu1.vn
Quarterly Risk: What is the next catalyst for BriaCell Therapeutics CorpJuly 2025 Weekly Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants - The Globe and Mail
Market Trends: Does BriaCell Therapeutics Corp Equity Warrant stock have upside surprise potentialGDP Growth & Stock Market Timing Techniques - baoquankhu1.vn
Aug Catalysts: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sectorWeekly Profit Analysis & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
U.S. Retail Sales Rise 0.6% MoM, Tech Stocks Decline - Intellectia AI
Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November - Benzinga
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1% - Intellectia AI
The $69B Precision Pivot: Why Biomarker Platforms are Igniting a New Oncology Gold Rush - The Globe and Mail
BriaCell Therapeutics Prices $30 Million Offering Amid 53.75% Stock Plunge - Intellectia AI
US-listed shares of BriaCell Therapeutics tumble 55% after company prices $30 mln public offering - marketscreener.com
Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
BriaCell Therapeutics stock plummets after $30 million offering By Investing.com - Investing.com Nigeria
BriaCell Therapeutics stock plummets after $30 million offering - Investing.com
BriaCell Therapeutics Down 55% in Pre-Market, Announces US$30 Million Offering - marketscreener.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
What's Going On With BriaCell Therapeutics Stock Wednesday? - Benzinga
BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7% - GuruFocus
BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering - Nasdaq
BriaCell Therapeutics Brief: Announced Overnight Pricing Of US$30 Million Public Offering - marketscreener.com
BriaCell Therapeutics (BCTX) Prices Public Offering at $30M - Intellectia AI
BriaCell Therapeutics Prices $30 Million Public Offering of Stock, Warrants - marketscreener.com
BriaCell prices $30 million public offering of units at $5.59 each By Investing.com - Investing.com South Africa
Briacell Therapeutics Corp (BCTX) 財務データ
収益
当期純利益
現金流量
EPS
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):